Core Viewpoint - Lepu Medical's subsidiary, Lepu Medical Electronics, has received NMPA registration approval for its rechargeable implantable deep brain stimulators and related components, marking a significant advancement in the field of neuroregulation and providing new treatment options for Parkinson's disease patients [1] Group 1 - The approved products include a rechargeable implantable deep brain stimulator, implantable deep brain stimulation electrode components, and implantable deep brain stimulation extension lead kits [1] - Deep brain stimulation (DBS) technology involves neurosurgical procedures where electrodes are implanted in specific brain locations to deliver constant or intermittent electrical currents, modulating abnormal neural electrical activity [1] - The successful approval of the rechargeable implantable deep brain stimulator system is a key achievement for the company in the neuroregulation sector [1]